Condition: Benign Prostate Hypertrophy(BPH) · Renal Calculi · Ureteral Stones, Kidney Stones · Sponsor: Boston Scientific Corporation
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
This description comes directly from the study's public registry record.
Winnie Chen · 952-930-6000 · SALTregistry@bsci.com
Curtis Blackwell · 952-930-6000
Always discuss trial participation with your own doctor first.
| Mayo Clinic Phoenix | Phoenix, Arizona, United States | Recruiting |
| University of Miami Hospital | Miami, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Indiana University Medical Center | Indianapolis, Indiana, United States | Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06982235